TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame
- PMID: 22672528
- PMCID: PMC3502079
- DOI: 10.1186/1475-2867-12-22
TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame
Abstract
Cancer is a multifaceted molecular disorder that is modulated by a combination of genetic, metabolic and signal transduction aberrations, which severely impair the normal homeostasis of cell growth and death. Accumulating findings highlight the fact that different genetic alterations, such as mutations in tumor suppressor genes, might be related to distinct and differential sensitivity to _targeted therapies. It is becoming increasingly apparent that a multipronged approach that addresses genetic milieu (alterations in upstream and/or parallel pathways) eventually determines the response of individual tumors to therapy. Cancerous cells often acquire the ability to evade death by attenuating cell death pathways that normally function to eliminate damaged and harmful cells. Therefore impaired cell death nanomachinery and withdrawal of death receptors from cell surface are some of major determinants for the development of chemotherapeutic resistance encountered during treatment. It is therefore essential to emphasize underlying factors which predispose cells to refractoriness against TRAIL mediated cell death pathway and the relevant regulatory components involved. We bring to limelight the strategies to re-sensitize TRAIL resistant cells via vitamins to induce apoptosis.
Figures
Similar articles
-
New frontiers in promoting tumour cell death: _targeting apoptosis, necroptosis and autophagy.Oncogene. 2012 Dec 6;31(49):5045-60. doi: 10.1038/onc.2012.7. Epub 2012 Feb 6. Oncogene. 2012. PMID: 22310284 Review.
-
Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications.Drug Resist Updat. 2004 Apr;7(2):139-56. doi: 10.1016/j.drup.2004.03.002. Drug Resist Updat. 2004. PMID: 15158769 Review.
-
TRAIL and chemotherapeutic drugs in cancer therapy.Vitam Horm. 2004;67:365-83. doi: 10.1016/S0083-6729(04)67019-1. Vitam Horm. 2004. PMID: 15110186 Review.
-
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.Cell Commun Signal. 2015 Apr 29;13:25. doi: 10.1186/s12964-015-0103-0. Cell Commun Signal. 2015. PMID: 25925126 Free PMC article.
-
TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.Mol Cancer Res. 2008 Dec;6(12):1861-71. doi: 10.1158/1541-7786.MCR-08-0313. Mol Cancer Res. 2008. PMID: 19074831
Cited by
-
Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells.Cancer Sci. 2017 Mar;108(3):373-379. doi: 10.1111/cas.13151. Cancer Sci. 2017. PMID: 28032932 Free PMC article.
-
Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.Cancer Cell Int. 2014 Apr 17;14:34. doi: 10.1186/1475-2867-14-34. eCollection 2014. Cancer Cell Int. 2014. PMID: 24739220 Free PMC article. Review.
-
Algae extracts and methyl jasmonate anti-cancer activities in prostate cancer: choreographers of 'the dance macabre'.Cancer Cell Int. 2012 Nov 26;12(1):50. doi: 10.1186/1475-2867-12-50. Cancer Cell Int. 2012. PMID: 23181808 Free PMC article.
-
Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.J Biol Chem. 2016 Aug 19;291(34):17861-80. doi: 10.1074/jbc.M116.718536. Epub 2016 Jun 24. J Biol Chem. 2016. PMID: 27342777 Free PMC article.
-
Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.Int J Mol Sci. 2017 Feb 22;18(2):473. doi: 10.3390/ijms18020473. Int J Mol Sci. 2017. PMID: 28241429 Free PMC article. Review.
References
-
- Farooqi AA, Rana A, Riaz AM, Khan A, Ali M, Javed S, Mukhtar S, Minhaj S, Rao JR, Rajpoot J, Amber R, Javed FA, Waqar-Un-Nisa, Khanum R, Bhatti S. NutriTRAILomics in prostate cancer: time to have two strings to one's bow. Mol Biol Rep. 2011;39(4):4909–4914. - PubMed
LinkOut - more resources
Full Text Sources